Unihealth Consultancy Limited IPO Message Board (Page 4)

Big 💪 big congratulations to the GARGI family members. Yesterday it touched its ATH LEveL @ 319.90 . PNGS grow ☝💪from 30 to 319 in just less than a year which is really very unbelievable.

I think something is cooking in this stock like bonus / split / right issue may be the reason for this upward movement. Does anyone who holds & know the reason , please share it.
Happy Holiday & Happy investing journey.

​@abc xyz Sold at 111 for IPO allotted lot.. It was my 1st SME IPO allotment.
Now regret.
Tracking after sold it went to near 200 than corrected to 90 try to buy at that but not able to buy due to fear of loss. Now it went to 330.

​@SMEARV  you should not regret.. you still got very handsome profit in this IPO..

Clear cut avoid. African business is very risky. Look at what happened with Balaxi pharma African subsidy to know how terrible writedowns can be!!!

On a light note:
Gabbar: Ab Unihealth kaa kya hoga kaliya?
Kaliya: Sardar ye tho gayyoo. Isne Africa kaa namak khaya hain.
Gabbar: Ahh thu. Ab discount listing ki goli kha..

I was expecting a discount listing here. Probably Unistone LM saved the day here!!! This is a company promoted by a builder choosing to do ground business in the most difficult place on Earth ,ie, Africa!!!

SaintCap - 342000 = 27.56%
LRSD Sec - 304000 - 22.11%
Leading Light - 218000 = 16.58%
RJ global - 152000 = 11.05%
Vikasa - 126000= 11.05%
Stern Global - 76000 = 11.64%

Boko Haram Mathematics (Uganda Nigeria)
152000 ,126000 both 11.05%
76000 (11.64%) < 11.05 %

Will it amount to misleading NSE and/or investers?

​@Logij Kumar Kya baat hai ganit me jyada number aate the kya?
Jis tarah ki gadbad ki hai usse lagta hai ye KHICHDI ka prfool parekh hoga, math class lene ki jagah ulta class lag na jaye.

Anchor allocation

@Admin @ Chittorgarh.com @Prachi @ Team Chittorgarh.com 
Can you please add "GMP on IPO closing day" column on IPO performance tracker page. This will help many people to analyse the performance, who consider GMP while applying IPOs.

gmp 30

Anchor list

Ancher List?

Dependable LM with a track record of positive listings
Blockbuster anchor book
Company is a holding company having 8 step down JV/subsidiary/associates in hospital and non-hospital business verticals
The Company has entered into a Memorandum of Understanding (MoU) with Myanmar based company on May 14, 2023, to manage its upcoming hospital in Myanmar and also explore the possibility of setting up of Nursing, Para-Medical and Medical College and Training Institutes in Myanmar. If this materialises, it would cause upward re-rating.
Between Mar-Jun ’18 company did private placement at Rs 1100 per share which post bonus works out to be Rs 137.5 per share and in 2023, 5 years later company is doing an IPO @ Rs 132. If 5 years interest cost is added to the private placement price, then current IPO price is highly discounted. Why would company offer such steep discount?
Company is deploying Rs 17 cr of IPO proceeds in Kampala Uganda hospital where it has 50% stake. Who are the other 50% owners, what is their contribution? Will company’s stake remain same or it will increase after this investment? If other joint owners are keeping their stake @ 50% without contributing, then Indian shareholders are at loss.
Similar concern with Nigeria hospital where company is deploying Rs 4.6 cr
Good cashflow for 20-21 and 21-22. 22-23 cash flow was strained due to YoY jump in receivables of Rs 9 cr.
Revenue, EBITDA and net asset split is not provided by verticals i.e. hospital and non-hospital
At Rs 27 cr, receivables are 7.7 months (234 days) of 22-23 sales. Assuming that hospital vertical would have 90 days of receivables, the non-hospital vertical would be having very high receivables compared to its sales.
Out of receivables of Rs 27 cr, Rs 15 cr are outstanding for more than 6 months and Rs 6 cr is outstanding for more than 1 year.
47% jump in other expenses is mostly due to increase in consultancy charges (from Rs 70 lacs to Rs 266 lacs), increase in professional and legal fees (from Rs 30 lacs to Rs 139 lacs) and increase in locum and specialist charges (from Rs 284 lacs to Rs 360 lacs).
Forex gain in 22-23 was Rs 121 lacs compared to Rs 53 lacs in previous year. Given that 96% of revenue is generated from overseas operations, this may very well continue in future.

This is a company promoted by real estate developer Aditya Builders Katariya family of Pune.

Hos
25rs buyer

ATTENTION - ALL IPO - SME IPO INVESTORS
We all know that strong Bull Run is going on in IPOs and SME IPOs and investors are making good money. But at the same time, investors should remain cautious as few companies may also come up with bad intentions
Before Investing do your own Research

Be 💣careful सावधान और सतर्क रहें !
सावधानी हटी और दुर्घटना🚙💥🚗 घटी ‌!
आपका पैसा आप की मर्जी!

Points Noteworthy :

1. Tax Litigations of around 827.36 lakhs
2. 65% of Total Revenue is dependent on one Victoria Hospital
3. Mostly all hospitals, Joint ventures are Outside India except one subsidiary recently acquired in India. Other Indian Biz includes Project Consultancy
4. Only one peer mentioned that has expensive valuations as compared to Unihealth
5. Market Maker is Rikhav
6. Recent 1:7 bonus issue was at 1,050 which comes to 131.25 per share so 132 upper band is justified
7. Post issue P/E comes around 26.5, cheaper than peer P/E of 44.88
8. 342 lakhs advances given to related parties
9. 2205 lakhs loan taken from related parties
10. From 618 lakhs to 1507 lakhs, receivables have increased that are outstanding for 6 or more months
11. Increase in consultancy, legal, professional charges by 3-4 times compared to FY 21-22
12. 25 lakhs Unsecured Loan from HDFC at 14%
13. Also defaulted in equipment payment of around 4300$ for which litigation is ongoing
14. Consistently higher trade payable days than trade receivable days are reduced in FY 24 and FY 25 estimates
15. Revenue estimate for FY 24 comes at 10,890.5 lakhs, i.e. 136% revenue growth estimate.
16. Cash cycle estimate is around 96 days from FY 24, so assuming the business being less capital intensive

Any premium aur subject 2 rate started ?

​@Gaurav DD dimer @MRavichandran @Arjun Rajkot RBM doubled in a month or so. Continuous orders. Holding finally paid off. Also all the orders have longer time frame adequate for medium-long term.

How much still it can fly?

RBM Lot size is Going to reduce from November first Week.

Announcement/Notification for same expected in first week of October.

& Results also in October /November.

Sirjee where you are, hoping everything is fine.
your inputs is very useful, request you to kindly share

The company has presence in multiple verticals of a fast-growing industry sector. With established presence in high-growth markets of Africa, the future prospects for growth look promising. Young promoters from the medical background and 13+ years of experience in the industry provide an added advantage.

wow sir
welcome to chhitorgarh forum
ur first comment nd that too in this ipo
also congratulations for this

New account for promotion.

How to manage funds this ipo season? May he this itself can be a new job 😆

Very much true sir 😊

Expensive valuation